Stock STE STERIS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials STERIS plc

Equities

STE

IE00BFY8C754

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
203.9 USD +1.17% Intraday chart for STERIS plc +2.20% -7.25%
Apr. 19 Wolfe Research Adjusts STERIS Price Target to $235 From $245 MT
Apr. 11 Sector Update: Health Care Stocks Steady Pre-Bell Thursday MT

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 10,830 11,871 16,258 24,208 18,991 20,148 - -
Enterprise Value (EV) 1 10,830 11,871 16,258 24,208 18,991 23,091 22,561 21,995
P/E ratio 36 x 29.4 x 41.1 x 97.5 x 179 x 37.2 x 30.2 x 26.7 x
Yield 1.04% 1.04% 0.82% 0.7% 0.96% 1% 1.09% 1.2%
Capitalization / Revenue 3.94 x 3.92 x 5.23 x 5.28 x 3.83 x 3.69 x 3.52 x 3.33 x
EV / Revenue 3.94 x 3.92 x 5.23 x 5.28 x 3.83 x 4.23 x 3.94 x 3.63 x
EV / EBITDA 15.6 x 15.8 x 19.6 x 20.5 x 14.1 x 15.7 x 14.5 x 13.1 x
EV / FCF 30.5 x 31.2 x 36.1 x 60.9 x - 33.8 x 28.3 x 20 x
FCF Yield 3.28% 3.2% 2.77% 1.64% - 2.96% 3.53% 5.01%
Price to Book 3.4 x - 4.19 x - - 3.15 x 2.94 x 2.75 x
Nbr of stocks (in thousands) 84,587 84,813 85,352 100,127 99,284 98,814 - -
Reference price 2 128.0 140.0 190.5 241.8 191.3 203.9 203.9 203.9
Announcement Date 5/13/19 5/13/20 5/18/21 5/11/22 5/10/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Maart 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,748 3,031 3,108 4,585 4,958 5,459 5,725 6,051
EBITDA 1 693.6 751.8 829.1 1,182 1,346 1,469 1,559 1,685
EBIT 1 557 628.6 699.4 1,077 1,170 1,260 1,352 1,429
Operating Margin 20.27% 20.74% 22.51% 23.48% 23.6% 23.08% 23.62% 23.62%
Earnings before Tax (EBT) 1 369.5 498.7 - 314.5 157.3 703.6 824.5 946
Net income 1 304.1 407.6 397.4 243.9 107 544.1 641.4 734.9
Net margin 11.07% 13.45% 12.79% 5.32% 2.16% 9.97% 11.2% 12.14%
EPS 2 3.560 4.760 4.630 2.480 1.070 5.476 6.742 7.643
Free Cash Flow 1 355.4 380.2 450.4 397.2 - 684 797.1 1,101
FCF margin 12.93% 12.54% 14.49% 8.66% - 12.53% 13.92% 18.2%
FCF Conversion (EBITDA) 51.24% 50.57% 54.32% 33.62% - 46.57% 51.13% 65.36%
FCF Conversion (Net income) 116.86% 93.28% 113.33% 162.88% - 125.7% 124.28% 149.84%
Dividend per Share 2 1.330 1.450 1.570 1.690 1.840 2.030 2.227 2.437
Announcement Date 5/13/19 5/13/20 5/18/21 5/11/22 5/10/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 1,197 1,209 1,211 1,156 1,201 1,216 1,385 1,285 1,342 1,396 1,430 1,324 1,374 1,429 1,476
EBITDA 1 321.8 330.2 359.8 308.1 325.4 334.7 376.3 329.5 355.2 369.5 393.9 351.8 367.8 384.2 405.1
EBIT 1 278.5 289.9 286.1 264.8 285.3 290.7 329.2 287.4 302 322.7 340.6 299.7 315 336.4 356.5
Operating Margin 23.27% 23.98% 23.63% 22.89% 23.77% 23.9% 23.77% 22.37% 22.5% 23.12% 23.82% 22.64% 22.93% 23.54% 24.16%
Earnings before Tax (EBT) 1 89.61 - - 135 -333.1 160.3 195.1 157.9 150.2 179.3 216.2 165 193.5 216.1 243.8
Net income 1 69.81 143.6 52.26 111.3 -315.3 123.8 187.2 123.6 115.3 140.7 164 135.1 146.9 163.9 180.3
Net margin 5.83% 11.88% 4.32% 9.62% -26.26% 10.18% 13.52% 9.62% 8.59% 10.08% 11.47% 10.2% 10.7% 11.47% 12.22%
EPS 2 0.6900 1.420 0.5200 1.100 -3.150 1.240 1.880 1.250 1.160 1.420 1.650 1.360 1.473 1.640 1.797
Dividend per Share 2 0.4300 0.4300 0.4300 0.4300 0.4700 0.4700 0.4700 0.4700 0.5200 0.5200 0.5200 0.5200 0.5650 0.5650 0.5650
Announcement Date 11/2/21 2/8/22 5/11/22 8/2/22 11/9/22 2/8/23 5/10/23 8/1/23 11/7/23 2/7/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 2,943 2,413 1,846
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - - - - - 2.004 x 1.548 x 1.096 x
Free Cash Flow 1 355 380 450 397 - 684 797 1,101
ROE (net income / shareholders' equity) 13% 14.6% 14.6% 14.9% 13% 13.8% 14.5% 14.5%
ROA (Net income/ Total Assets) 8.13% 9.19% 8.82% 8.64% 7.39% 8.7% 9.4% 10.1%
Assets 1 3,741 4,433 4,506 2,822 1,448 6,254 6,823 7,276
Book Value Per Share 2 37.70 - 45.50 - - 64.80 69.30 74.30
Cash Flow per Share - - - 6.960 - - - -
Capex 1 190 215 239 288 362 310 361 371
Capex / Sales 6.9% 7.08% 7.7% 6.27% 7.3% 5.68% 6.3% 6.14%
Announcement Date 5/13/19 5/13/20 5/18/21 5/11/22 5/10/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for STERIS plc

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
203.9 USD
Average target price
239.9 USD
Spread / Average Target
+17.64%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
STERIS PLC Stock STERIS plc
-7.25% 20.15B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. STE Stock
  4. Financials STERIS plc